Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Are Canadian Marijuana Stocks A Good Investment Before 2022? The post Best Canadian Pot Stocks For Your December 2021 Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Pot Stocks For Your December 2021 Watchlist

The world's biggest pot stock doesn't wear its crown easily.

Tilray Stock: Bull vs. Bear

Canopy Growth

U.S. legalization is still stalled, but Mexican marijuana legalization could be imminent.

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Dropped Today

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Implied Volatility Surging for Tilray (TLRY) Stock Options

Snowflake

California State Teachers' Retirement System bought AMC Entertainment, Snowflake, and marijuana stock Tilray in the third quarter. It sold Berkshire Hathaway stock.

Giant U.S. Pension Bought AMC, Snowflake, and Tilray. It Sold Berkshire Hathaway.

Flora Growth Corp

Akerna Corp

OrganiGram Holdings Inc.

Uber

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

Green Wednesday Lit Up These 6 Marijuana Stocks

DraftKings

Vail Resorts

Pinterest

Entertainment stocks to note as growth stocks lose momentum in the stock market now.

4 Entertainment Stocks For Your Watchlist Today

TLRY stock moves fast short term, but the real story needs years to develop. In the meantime, it has a base on which to mount another bounce.

How to Rinse and Repeat With Tilray Stock for an Easy Win

Cannabis Growth ETF

Amplify Seymour Cannabis ETF

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

Amplify US Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Advisorshares Poseidon Dynamic Cannabis ETF

Trulieve Cannabis Corp.

AXS Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Timely, edifying episode with industry expert Brady Cobb. Recent cannabis legislation; moving from optics to real reform. SAFE Banking, uplisting and what it all means for cannabis investors.

Cannabis Stocks Are A Coiled Spring - Industry Update With Brady Cobb (Podcast)

On Monday, Canadian cannabis giant Tilray, Inc. (NASDAQ:TLRY) (TSX:TLRY) held its first annual meeting of shareholders as the 'new' Tilray, following the merger with Aphria, Inc. in May. "In just six months, we have made concrete and measurable progress integrating our operations while capitalizing on the fast-growing consumer demand for wellness and consumer lifestyle products," Irwin D.

The 'New' Tilray: Highlights From First Annual Shareholders Meeting

2 Marijuana Stocks To Watch The Week Of Thanksgiving The post Top Marijuana Stocks To Watch During The Holiday Season appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks To Watch During The Holiday Season

Chairman and CEO Irwin D. Simon Affirms Global Growth Strategy, Driven by Strong Positioning across the EU, Canada, and the U.S.

Tilray Hosts 2021 Annual Meeting of Shareholders

The market's still skeptical about TLRY stock and other cannabis names, but this factor may work in your favor. The post Tilray Remains a Solid Pot Play appeared first on InvestorPlace.

Tilray Remains a Solid Pot Play

Cannabis name Tilray Inc (NASDAQ:TLRY) is slipping today, last seen down 3.2% to trade at $10.59.

Options Bulls Double Down on Flailing Cannabis Stock

If you look at the long view, the recent past is a blip.

Down 30% in 6 Months: Is Tilray Still a Buy?

The cannabis company has some pretty big ambitions for the next few years.

Is Tilray a Buy?

TLRY stock represents one of the bigger Canadian cannabis operations -- and it has done well. But is that enough reason to buy Tilray now?

Tilray Received Some Good News, But Is It Enough?

Cronos Group

HEXO Corp

SNDL Inc.

An analyst initiated coverage on three of the stocks, but all of them fell as a result.

Why Canopy Growth, Cronos, Hexo, Sundial, and Tilray Stocks Are Plunging This Week

Barclays has issued a report that has cast doubt over an entire industry and has sent cannabis stocks plunging. Should you be worried?

Cannabis Stocks: How One Analyst Just Snuffed Out TLRY, CRON, CGC Stocks

Tilray, Inc. (NASDAQ:TLRY) shares are trading lower after Barclays initiated coverage on the stock with an Underweight rating and a $10 price target. Barclays analyst Gaurav Jain notes 'the US leaf touching businesses remain federally illegal and we see little likelihood of legalization under the Biden administration.

Why Tilray Shares Are Falling

Senator Schumer's "big boys" comment causes big losses for cannabis stocks.

Why Tilray, Cronos, and Curaleaf Stocks Dropped Today

Tilray is slowly moving into the U.S. but it may soon face dilution. TLRY stock could fall if shares are issued to reach a revenue goal.

Tilray Is Creeping Into the U.S., But Its Sales Goal May Lead to Dilution

Barclays analyst Guarav Jain on Thursday initiated coverage of three cannabis stocks but said their businesses are limited by the relatively small size of the legal market in Canada. Barclays launched overage of Tilray TLRY, -4.86% and Cronos CRON, -4.48% with an underweight rating and price targets of $10 and $5.50 respectively.

Barclays initiates coverage of Tilray, Cronos and Canopy Growth

AMC Entertainment

Advanced Micro Devices

Ford Motor Company

GameStop

NVIDIA

Palantir Technologies

PayPal

Tesla

United States Steel

Meme stocks are central to the retail investor revolution. However, only some of the top-mentioned picks on Reddit are actually worth buying.

The Top 10 Meme Stocks on Reddit: Should You Buy, Sell or Hold?

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Tilray, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), invites all stockholders of record to attend the Annual Meeting of Stockholders (“Annual Meeting”) which will be held on November 22, 2021 at 11:00 a.m. EST. The record date for the Annual Meeting was September 24, 2021. In light of the ongoing public health crisis caused by the COVID-19 pandemic, the Annual Meeting will be held in a virtual format only, via live webcast over the internet.

Tilray to Webcast Annual Meeting of Stockholders on November 22, 2021

News for Tilray Brands Stock (TLRY)